Switzerland· 56007002
Forsteo
A teriparatide product containing teriparatidum adnr, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Teriparatide is registered in 18 of 19 countries.
Countries holding a registration under ATC H05AA02 (teriparatide), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 10 of them publish a price we can compare per daily dose
Teriparatide · ATC H05AA02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of teriparatide costs, country by country.
Normalised to the WHO defined daily dose (20 mcg), so markets compare like for like.
- Switzerland: $26.86 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Teriparatide · price per daily dose (20 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$26.86
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- teriparatidum ADNr
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- H05AA02
- ATC class
- Teriparatide
- Defined daily dose
- 20 mcg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680560070021Patrone 2.4 mlCHF 305.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for teriparatide.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Teriparatide · interactions on record
6 records
- 4 moderate
- 2 minor
Most severe, free to view
- DigitoxinC01AA04moderate
- DigoxinC01AA05moderate
- CalcipotriolD05AX02moderate
- CalcitriolD05AX03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Teriparatide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFORSTEOEli Lilly Nederland B.V., Utrecht
- PolandForsteoEli Lilly Nederland B.V.
- SpainDURATIL 20 MICROGRAMOS/80 MICROLITROS SOLUCION INYECTABLE EN PLUMA PRECARGADA EFGGp Pharm S.A.
- United StatesBonsityAlvogen Inc.
- FinlandForsteoOrifarm Oy
- NetherlandsForsteo 20 microgram/80 microliter, oplossing voor injectie in voorgevulde penEli Lilly Nederland BV
- United KingdomForsteo 20micrograms/80microlitres dose solution for injection 2.4ml pre-filled pensEli Lilly and Company Ltd
- SwedenForsteo 20 mikrogram/80 mikroliter Injektionsvätska, lösning i förfylld injektionspennaEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Teriparatid +pharma, Teriparatid Cipla
- Bulgaria · Osteoteri
- Cyprus · Bonamens
- Germany · Osteoteri, Teriparatid Ambio Pharma
- Denmark · Tetridar
- Spain · Duratil, Osdy
- France · Teriparatide Ambio Pharma, Teriparatide Biogaran
- United Kingdom (Northern Ireland) · Movymia, Teriparatide Ambio Pharma
- Greece · Bonamens, Osteorel
- Croatia · Teriparatid Pliva
- Hungary · Osteoteri, Teriparatid Teva
- Ireland · Teriparatide Cipla, Tetridar
- Iceland · Forsteo, Kauliv
- Italy · Oseffyl, Patride
- Liechtenstein · Forsteo, Kauliv
- Netherlands · Teriparatide Ambio Pharma, Teriparatide Aristo
- Norway · Forsteo, Kauliv
- Poland · Osteoteri
- Portugal · Teriparatida Ratiopharm
- Sweden · Teriparatide Ambio Pharma, Teriparatide Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/64bc1e8f-9d8a-484c-8fd5-dbbd23dca9e3 GET /v1/drugs/64bc1e8f-9d8a-484c-8fd5-dbbd23dca9e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "teriparatidum adnr 250 mcg",
"valid_from": "2005-11-01",
"limitations": "[{\"description\":\"Zur second line-Behandlung von postmenopausalen Frauen und Männern mit neuen radiologisch dokumentierten osteoporosebedingten Wirbelkörperfrakturen, die nach einer mindestens 6-monatigen Therapie mit Calcitonin, SERM (selektiver Oestrogen-Rezeptor-Modulator), Denosumab oder einem Bisphosphonat auftraten.<br>\\nZur Behandlung von Männern und Frauen mit etablierter Glukokortikoid-induzierter Osteoporose (GIOP) bei ungenügender Wirksamkeit oder schlechter Verträglichkeit einer Therapie mit einem Bisphosphonat.<br>\\nMaximale Therapiedauer 24 Monate.<br>\\nDie Indikationsstellung darf nur durch Fachärzte (Endokrinologen, Rheumatologen) erfolgen. \\n\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2009-08-01\",\"validTo\":null}]",
"galenic_form": "Inj Lös",
"therapeutic_area": null,
"sl_inclusion_date": "2005-11-01",
"self_retention_pct": 40
}See everything about teriparatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.